Prednisolone NDC 50090-7115

NDC codes

FDA NDC Directory

Product NDC (as listed)50090-7115Labeler and product segments. Claims need a package NDC.

Product NDC at billing width50090-7115Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
50090-7115-0	50090711500	2 BOTTLE, DISPENSING in 1 BOTTLE (50090-7115-0) / 120 mL in 1 BOTTLE, DISPENSINGMarketed from Mar 12, 2024
50090-7115-1	50090711501	4 BOTTLE, DISPENSING in 1 BOTTLE (50090-7115-1) / 60 mL in 1 BOTTLE, DISPENSINGMarketed from Mar 12, 2024

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Prednisolone
Generic name (nonproprietary): prednisolone
Active ingredients: Prednisolone — 15 mg/5mL
Dosage form: Solution
Route: Oral
Labeler: A-S Medication Solutions
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 040571
Marketing start: Sep 12, 2023
Listing expires: Dec 31, 2027
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 50090-7115_9a49f696-0cdf-45d7-adc4-f1cb1fbb690bSPL ID 9a49f696-0cdf-45d7-adc4-f1cb1fbb690bSPL set ID 35f0b197-c3ae-445a-8da7-9ffcd4472e05RxCUI 283077UNII 9PHQ9Y1OLM
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N450090711500 followed by a unit qualifier and the quantity

Package 50090-7115-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 23, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Prednisolone Oral Solution USP is indicated in the following conditions: 1. Endocrine Disorders Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice: synthetic analogs may be used in conjunction with mineralocorticoids where applicable: in infancy mineralocorticoid supplementation is of particular importance). Congenital adrenal hyperplasia Nonsuppurative thyroiditis Hypercalcemia associated with cancer 2. Rheumatic Disorders As adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in: Psoriatic arthritis Rheumatoid arthritis, including juvenile rheumatoid arthritis (sel…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 040571

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 040571
Product	Strength	Form · route	Labeler	Product NDC
Prednisolone	Prednisolone 15 mg/5mL	SolutionOral	PAI Holdings, LLC dba PAI Pharma	0121-0885